CapitalCandor
← Back to matches

Harborlight Ventures

Series A/B investor focused on healthcare and biotech innovation.

vc fund · Boston, MA · Founded 2012

28/ 100 fit for the demo profile
Low PriorityConfidence: Low

Last verified: April 14, 2026

Fit breakdown

Sector / Thesis
10
Confidence: High
Funding Stage
18
Confidence: High
Check Size
70
Confidence: High
Portfolio Similarity
33
Confidence: Low
Recent Investment Behavior
0
Confidence: Medium
Geography
20
Confidence: High
Lead / Follow Preference
100
Confidence: High

Stated vs. observed preferences

When an investor's public thesis and recent behavior diverge, CapitalCandor shows both — never silently overwriting one with the other.

Stage

Stated: series_a, series_bConfidence: High
Observed: no recent observed dataConfidence: Unknown

Sectors

Stated: biotech, digital health, life sciencesConfidence: High
Observed: no recent observed dataConfidence: Unknown

Check size

Stated: $3,000,000 – $10,000,000Confidence: High
Observed: no recent observed dataConfidence: Unknown

Lead / Follow

Stated: leadConfidence: High
Observed: no recent observed dataConfidence: Unknown

Portfolio & recent investments

CompanySectorStageCheck sizeLead
Cellastra Therapeuticsbiotechseries a$6,000,000Lead
Vitalyze Healthdigital healthseries b$8,000,000Lead
Genomorabiotechseries a$5,500,000Follow

Evidence

biotech, digital health, life sciencesConfidence: High
Confirmed portfolio/funding announcementDirectly statedLast verified: April 14, 2026
series_a, series_bConfidence: High
Confirmed portfolio/funding announcementDirectly statedLast verified: April 14, 2026
$3,000,000 - $10,000,000Confidence: High
Confirmed portfolio/funding announcementDirectly statedLast verified: April 14, 2026
United StatesConfidence: High
Confirmed portfolio/funding announcementDirectly statedLast verified: April 14, 2026
leadConfidence: High
Confirmed portfolio/funding announcementDirectly statedLast verified: April 14, 2026
Cellastra Therapeutics (biotech, series_a)Confidence: High
Confirmed portfolio/funding announcementDirectly statedLast verified: April 14, 2026
Vitalyze Health (digital health, series_b)Confidence: High
Confirmed portfolio/funding announcementDirectly statedLast verified: April 14, 2026
Genomora (biotech, series_a)Confidence: High
Confirmed portfolio/funding announcementDirectly statedLast verified: April 14, 2026